NCT05082818

Brief Summary

Retrospective study of outcome of urinary bladder cancer treated in Sohag University hospital in the past 5 years from 2016 to 2020

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 19, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

October 30, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

June 14, 2022

Status Verified

June 1, 2022

Enrollment Period

7 months

First QC Date

October 15, 2021

Last Update Submit

June 12, 2022

Conditions

Bladder Cancer

Outcome Measures

Primary Outcomes (1)

  • Disease free survival

    Time from the end of treatment to the date of first relapse

    2 weeks after treatment to the time of relapse

Interventions

Chemotherapy, Radiotherapy and surgeryCOMBINATION_PRODUCT

Trans urethral resection of the tumour or radical cystectomy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Bladder cancer patients of both sex and aged from 18 to 80 years old

You may qualify if:

  • all stages and grades of urinary bladder cancer Any histological types of urinary bladder cancer

You may not qualify if:

  • presence of other malignancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

Location

MeSH Terms

Conditions

Urinary Bladder Neoplasms

Interventions

Drug TherapyRadiotherapySurgical Procedures, Operative

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Samah Refaat

    Sohag University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident of clinical oncology faculty of medicine Sohag University

Study Record Dates

First Submitted

October 15, 2021

First Posted

October 19, 2021

Study Start

October 30, 2021

Primary Completion

May 28, 2022

Study Completion

May 30, 2022

Last Updated

June 14, 2022

Record last verified: 2022-06

Locations

EG(1)